Delivery Order SPE2DB22D3102-SPE2DB25FL2JF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamotrigine ER 250 mg tablets (30-count) with a ceiling value of $1,343.58 under a firm fixed-price contract type. The award was made on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a non-set-aside, competitively awarded transaction. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,336.23 to AmerisourceBergen Drug Corp for Lamotrigine ER 300 mg tablets (30-count supply) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lamotrigine is a neurological medication commonly used to treat epilepsy and bipolar...
- The Defense Logistics Agency awarded a delivery order valued at $4,824.31 to AmerisourceBergen Drug Corp for Lamotrigine ER 50 mg tablets (30-count) on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Lamotrigine is a neurological medication commonly used for seizure management and bipolar...
- The Defense Logistics Agency awarded a delivery order valued at $1,910.41 to AmerisourceBergen Drug Corp for the supply of Lamotrigine ER 250 mg tablets (30-count packages). This contract, awarded on August 5, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Lamotrigine ODT 200 mg tablets in quantities of 30 units, valued at $1,269.11. This firm fixed-price delivery order, set to be completed by August 8, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The award was competitively awarded without set-aside provisions, reflecting the vendor's demonstrated capability...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Lamotrigine ER 25 mg tablets. The contract has a ceiling value of $4,212.78 and a period of performance through February 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $35,660 firm fixed price delivery order contract to provide 4562339082 Lamotrigine ER 25 MG tablets. As the prime contractor, Amerisourcebergen will deliver 30 count bottles of the generic anti-seizure medication to a Defense Department facility located in Conshohocken, Pennsylvania between September 28-29, 2023. The contract was awarded under the parent company Amerisourcebergen Corporation's Federal Supply Schedule...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,596.03, is for the delivery of Lamotrigine ER 300 mg tablets, a medication used to treat seizures and certain types of mental health conditions. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 21, 2025. This award is part of a larger Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamotrigine ER 50 mg tablets. The contract is a firm-fixed price arrangement with a ceiling value of $7,987.56 and a period of performance through August 13, 2024. This award does not utilize any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamotrigine ER 100 mg tablets. The contract has a ceiling value of $1,464.53 and a period of performance ending on September 24, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2JFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Lamotrigine ER 25 mg tablets in quantities of 30, with a ceiling value of $1,517.04. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Lamotrigine is a neurological medication commonly used in the treatment of epilepsy and mood disorders within military and veteran healthcare systems. AmerisourceBergen's delivery orders under the SPE2DX vehicle reflect the company's role as a critical vendor for federal medical procurement, delivering pharmaceuticals across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support Medical Supply Chain has positioned AmerisourceBergen as one of several pharmaceutical prime vendors capable of meeting federal requirements through open competition and flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/1/25 |